context
pandem
grow
tension
worldwid
regard
healthcar
facil
urgent
need
effect
treatment
like
reduc
crunch
icu
bed
follow
assumpt
mehta
colleagu
exhort
physician
screen
patient
sever
hyperinflamm
investig
immunomodulatori
drug
set
relat
shortterm
yet
promis
experi
regard
blockad
tocilizumab
select
patient
less
year
age
day
prior
diseas
durat
sever
ie
requir
strictli
oxygen
therapi
rapidli
deterior
ie
increas
oxygen
flow
within
previou
hour
pneumonia
comparison
control
group
patient
match
age
gender
diseas
sever
use
invers
probabl
treatment
weight
methodolog
receiv
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
context
pandem
grow
tension
worldwid
regard
healthcar
facil
urgent
need
effect
treatment
like
reduc
crunch
icu
bed
follow
assumpt
mehta
colleagu
exhort
physician
screen
patient
sever
hyperinflamm
investig
immunomodulatori
drug
set
relat
shortterm
yet
promis
experi
regard
blockad
tocilizumab
select
patient
less
year
age
day
prior
diseas
durat
sever
ie
requir
strictli
oxygen
therapi
rapidli
deterior
ie
increas
oxygen
flow
within
previou
hour
pneumonia
comparison
control
group
patient
match
age
gender
diseas
sever
use
invers
probabl
treatment
weight
methodolog
receiv
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tocilizumab
demonstr
highli
select
patient
blockad
could
curb
cytokin
storm
prevent
icu
admiss
requir
mechan
ventil
notwithstand
shortcom
retrospect
small
samples
studi
believ
preliminari
find
support
foster
research
effort
fight
inflamm
especi
patient
requir
admiss
icu
grow
evid
virallyinduc
proinflammatori
cytokin
includ
interleukin
il
tumor
necrosi
granulocyt
coloni
stimul
factor
lead
hyperinflammatori
procoagulatori
state
latestag
diseas
find
corrobor
recent
studi
highlight
high
level
creactiv
protein
ddimer
upon
admiss
predictor
mortal
recent
comment
mehta
colleagu
exhort
physician
screen
patient
sever
hyperinflamm
suggest
immunosuppress
andor
immunomodulatori
drug
investig
set
relat
shortterm
yet
promis
experi
regard
blockad
sever
tocilizumab
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
discharg
icu
hospit
respect
overal
tocilizumab
welltoler
yet
mild
hepat
cytolysi
ventilatoracquir
pneumonia
report
note
patient
treat
tocilizumab
also
receiv
cours
hydroxychloroquin
tid
azithromycin
bid
qid
thereaft
patient
treat
tocilizumab
receiv
highdos
methylprednisolon
puls
context
pandem
grow
tension
worldwid
regard
healthcar
facil
urgent
need
effect
treatment
like
reduc
crunch
icu
bed
concord
assumpt
mehta
other
data
suggest
target
highli
select
patient
rapidli
deterior
pneumonia
high
inflammatori
paramet
could
curb
cytokin
storm
prevent
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
